Published in Hypertension on October 22, 2012
Reporter mouse strain provides a novel look at angiotensin type-2 receptor distribution in the central nervous system. Brain Struct Funct (2014) 0.91
Direct angiotensin AT2 receptor stimulation using a novel AT2 receptor agonist, compound 21, evokes neuroprotection in conscious hypertensive rats. PLoS One (2014) 0.90
AT(2) receptor and tissue injury: therapeutic implications. Curr Hypertens Rep (2014) 0.87
Angiotensin type 2 receptors: blood pressure regulation and end organ damage. Curr Opin Pharmacol (2015) 0.86
Neuroprotective mechanisms of the ACE2-angiotensin-(1-7)-Mas axis in stroke. Curr Hypertens Rep (2015) 0.81
Angiotensin receptor type 2 activation induces neuroprotection and neurogenesis after traumatic brain injury. Neurotherapeutics (2014) 0.80
Long-term survival and regeneration of neuronal and vasculature cells inside the core region after ischemic stroke in adult mice. Brain Pathol (2016) 0.79
Neuroprotection after traumatic brain injury in heat-acclimated mice involves induced neurogenesis and activation of angiotensin receptor type 2 signaling. J Cereb Blood Flow Metab (2014) 0.78
Transient filament occlusion of the middle cerebral artery in rats: does the reperfusion method matter 24 hours after perfusion? BMC Neurosci (2012) 0.78
Effect of a Selective Mas Receptor Agonist in Cerebral Ischemia In Vitro and In Vivo. PLoS One (2015) 0.77
Molecular programs induced by heat acclimation confer neuroprotection against TBI and hypoxic insults via cross-tolerance mechanisms. Front Neurosci (2015) 0.76
Neuroprotective effect of angiotensin II type 2 receptor during cerebral ischemia/reperfusion. Neural Regen Res (2016) 0.76
Therapeutic potential of the renin angiotensin system in ischaemic stroke. Exp Transl Stroke Med (2016) 0.75
Angiotensin II type 2 receptor agonists as therapies for ischemic stroke. Hypertension (2012) 0.75
Relationship between pre-stroke cardiovascular medication use and stroke severity. Eur J Clin Pharmacol (2015) 0.75
Post-stroke angiotensin II type 2 receptor activation provides long-term neuroprotection in aged rats. PLoS One (2017) 0.75
Apoptotic mechanisms after cerebral ischemia. Stroke (2009) 3.92
Inflammation, immunity, and hypertension. Hypertension (2010) 3.43
Combating oxidative stress in vascular disease: NADPH oxidases as therapeutic targets. Nat Rev Drug Discov (2011) 3.08
Enhanced angiotensin II type 2 receptor mechanisms mediate decreases in arterial pressure attributable to chronic low-dose angiotensin II in female rats. Hypertension (2008) 2.76
Role of interleukin 17 in inflammation, atherosclerosis, and vascular function in apolipoprotein e-deficient mice. Arterioscler Thromb Vasc Biol (2011) 2.27
Protective arms of the renin-angiotensin-system in neurological disease. Clin Exp Pharmacol Physiol (2013) 2.18
Direct evidence of a role for Nox2 in superoxide production, reduced nitric oxide bioavailability, and early atherosclerotic plaque formation in ApoE-/- mice. Am J Physiol Heart Circ Physiol (2009) 2.00
Angiotensin AT2 receptor stimulation causes neuroprotection in a conscious rat model of stroke. Stroke (2009) 1.95
High blood pressure reduction reverses angiotensin II type 2 receptor-mediated vasoconstriction into vasodilation in spontaneously hypertensive rats. Circulation (2005) 1.70
NADPH oxidase activity and function are profoundly greater in cerebral versus systemic arteries. Circ Res (2005) 1.65
Transient neuroprotection by minocycline following traumatic brain injury is associated with attenuated microglial activation but no changes in cell apoptosis or neutrophil infiltration. Exp Neurol (2006) 1.63
Inhibition of Nox2 oxidase activity ameliorates influenza A virus-induced lung inflammation. PLoS Pathog (2011) 1.62
Targeting Rho and Rho-kinase in the treatment of cardiovascular disease. Trends Pharmacol Sci (2005) 1.60
DC isoketal-modified proteins activate T cells and promote hypertension. J Clin Invest (2014) 1.59
NADPH oxidases in the vasculature: molecular features, roles in disease and pharmacological inhibition. Pharmacol Ther (2008) 1.58
Pathophysiology, treatment, and animal and cellular models of human ischemic stroke. Mol Neurodegener (2011) 1.48
AT2 receptors: functional relevance in cardiovascular disease. Pharmacol Ther (2008) 1.46
Evidence for a detrimental role of TLR8 in ischemic stroke. Exp Neurol (2013) 1.46
Serelaxin is a more efficacious antifibrotic than enalapril in an experimental model of heart disease. Hypertension (2014) 1.45
Nitroxyl (HNO): the Cinderella of the nitric oxide story. Trends Pharmacol Sci (2008) 1.44
Role of the adaptive immune system in hypertension. Curr Opin Pharmacol (2010) 1.44
Angiotensin AT2 receptor contributes to cardiovascular remodelling of aged rats during chronic AT1 receptor blockade. J Mol Cell Cardiol (2004) 1.40
Angiotensin-(1-7) acts as a vasodepressor agent via angiotensin II type 2 receptors in conscious rats. Hypertension (2005) 1.37
Mechanisms contributing to cerebral infarct size after stroke: gender, reperfusion, T lymphocytes, and Nox2-derived superoxide. J Cereb Blood Flow Metab (2010) 1.36
Vasoprotective and atheroprotective effects of angiotensin (1-7) in apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol (2010) 1.35
Oxidative stress and endothelial dysfunction in cerebrovascular disease. Front Biosci (Landmark Ed) (2011) 1.34
Nitroxyl anion donor, Angeli's salt, does not develop tolerance in rat isolated aortae. Hypertension (2007) 1.31
Relative affinity of angiotensin peptides and novel ligands at AT1 and AT2 receptors. Clin Sci (Lond) (2011) 1.29
Endothelium-dependent relaxation by G protein-coupled receptor 30 agonists in rat carotid arteries. Am J Physiol Heart Circ Physiol (2010) 1.29
Adiponectin receptor signalling in the brain. Br J Pharmacol (2012) 1.28
Inflammatory cell infiltration after endothelin-1-induced cerebral ischemia: histochemical and myeloperoxidase correlation with temporal changes in brain injury. J Cereb Blood Flow Metab (2006) 1.27
Multiphoton imaging reveals a new leukocyte recruitment paradigm in the glomerulus. Nat Med (2012) 1.23
Importance of T lymphocytes in brain injury, immunodeficiency, and recovery after cerebral ischemia. J Cereb Blood Flow Metab (2012) 1.22
Non-peptide AT2-receptor agonists. Curr Opin Pharmacol (2010) 1.15
NADPH oxidase isoform selective regulation of endothelial cell proliferation and survival. Naunyn Schmiedebergs Arch Pharmacol (2009) 1.15
Gender differences in pressure-natriuresis and renal autoregulation: role of the Angiotensin type 2 receptor. Hypertension (2010) 1.14
Ndfip1 regulates nuclear Pten import in vivo to promote neuronal survival following cerebral ischemia. J Cell Biol (2012) 1.13
A GLP-1 receptor agonist liraglutide inhibits endothelial cell dysfunction and vascular adhesion molecule expression in an ApoE-/- mouse model. Diab Vasc Dis Res (2011) 1.13
Effect of gender on NADPH-oxidase activity, expression, and function in the cerebral circulation: role of estrogen. Stroke (2007) 1.13
Sex-specific influence of angiotensin type 2 receptor stimulation on renal function: a novel therapeutic target for hypertension. Hypertension (2011) 1.12
Increased NADPH-oxidase activity and Nox4 expression during chronic hypertension is associated with enhanced cerebral vasodilatation to NADPH in vivo. Stroke (2004) 1.11
Spatio-temporal progression of grey and white matter damage following contusion injury in rat spinal cord. PLoS One (2010) 1.11
NADPH oxidase activity is higher in cerebral versus systemic arteries of four animal species: role of Nox2. Am J Physiol Heart Circ Physiol (2008) 1.10
Functional role of angiotensin II AT2 receptor in modulation of AT1 receptor-mediated contraction in rat uterine artery: involvement of bradykinin and nitric oxide. Br J Pharmacol (2003) 1.10
Recent evidence for an involvement of rho-kinase in cerebral vascular disease. Stroke (2006) 1.08
Evidence that gamma-secretase-mediated Notch signaling induces neuronal cell death via the nuclear factor-kappaB-Bcl-2-interacting mediator of cell death pathway in ischemic stroke. Mol Pharmacol (2011) 1.04
The central nervous system and inflammation in hypertension. Curr Opin Pharmacol (2010) 1.03
T lymphocytes and vascular inflammation contribute to stress-dependent hypertension. Biol Psychiatry (2012) 1.03
Effect of gender and sex hormones on vascular oxidative stress. Clin Exp Pharmacol Physiol (2007) 1.02
Flow-induced cerebral vasodilatation in vivo involves activation of phosphatidylinositol-3 kinase, NADPH-oxidase, and nitric oxide synthase. J Cereb Blood Flow Metab (2006) 1.02
NADPH oxidases as regulators of tumor angiogenesis: current and emerging concepts. Antioxid Redox Signal (2012) 1.02
Evidence that nitric oxide inhibits vascular inflammation and superoxide production via a p47phox-dependent mechanism in mice. Clin Exp Pharmacol Physiol (2009) 1.01
Chemokine-related gene expression in the brain following ischemic stroke: no role for CXCR2 in outcome. Brain Res (2010) 1.00
Inwardly rectifying potassium channels in the regulation of vascular tone. Curr Drug Targets (2003) 1.00
Sex differences in the pressor and tubuloglomerular feedback response to angiotensin II. Hypertension (2011) 1.00
Novel isoforms of NADPH-oxidase in cerebral vascular control. Pharmacol Ther (2006) 0.99
Early origins of cardiac hypertrophy: does cardiomyocyte attrition programme for pathological 'catch-up' growth of the heart? Clin Exp Pharmacol Physiol (2008) 0.99
AT2 receptor-mediated vasodilatation is unmasked by AT1 receptor blockade in conscious SHR. Br J Pharmacol (2004) 0.99
Reactive oxygen species in the cerebral circulation: are they all bad? Antioxid Redox Signal (2006) 0.99
NADPH-oxidase activity is elevated in penumbral and non-ischemic cerebral arteries following stroke. Brain Res (2006) 0.98
Role of vascular extracellular superoxide dismutase in hypertension. Hypertension (2011) 0.98
Endothelial cell mineralocorticoid receptors regulate deoxycorticosterone/salt-mediated cardiac remodeling and vascular reactivity but not blood pressure. Hypertension (2014) 0.97
Role of Nox isoforms in angiotensin II-induced oxidative stress and endothelial dysfunction in brain. J Appl Physiol (1985) (2012) 0.97
Nox isoforms in vascular pathophysiology: insights from transgenic and knockout mouse models. Redox Rep (2010) 0.97
Gender influences cerebral vascular responses to angiotensin II through Nox2-derived reactive oxygen species. Stroke (2009) 0.97
Update on the angiotensin AT(2) receptor. Curr Hypertens Rep (2013) 0.97
Importance of NOX1 for angiotensin II-induced cerebrovascular superoxide production and cortical infarct volume following ischemic stroke. Brain Res (2009) 0.97
Evidence that estrogen suppresses rho-kinase function in the cerebral circulation in vivo. Stroke (2004) 0.96
Segmental differences in the roles of rho-kinase and protein kinase C in mediating vasoconstriction. J Pharmacol Exp Ther (2006) 0.95
Vasorelaxant and antioxidant activity of the isoflavone metabolite equol in carotid and cerebral arteries. Brain Res (2007) 0.95
The GLP-1 receptor agonist liraglutide inhibits progression of vascular disease via effects on atherogenesis, plaque stability and endothelial function in an ApoE(-/-) mouse model. Diab Vasc Dis Res (2013) 0.95
A novel histone deacetylase inhibitor reduces abdominal aortic aneurysm formation in angiotensin II-infused apolipoprotein E-deficient mice. J Vasc Res (2007) 0.94
Nox2 oxidase activity accounts for the oxidative stress and vasomotor dysfunction in mouse cerebral arteries following ischemic stroke. PLoS One (2011) 0.94
Pathogenesis of acute stroke and the role of inflammasomes. Ageing Res Rev (2013) 0.94
Augmented superoxide production by Nox2-containing NADPH oxidase causes cerebral artery dysfunction during hypercholesterolemia. Stroke (2010) 0.94
Central autonomic integration of psychological stressors: focus on cardiovascular modulation. Auton Neurosci (2005) 0.93
Reversal of vascular macrophage accumulation and hypertension by a CCR2 antagonist in deoxycorticosterone/salt-treated mice. Hypertension (2012) 0.93
Enhanced depolarization-induced pulmonary vasoconstriction following chronic hypoxia requires EGFR-dependent activation of NAD(P)H oxidase 2. Antioxid Redox Signal (2012) 0.92
High methionine and cholesterol diet abolishes endothelial relaxation. Arterioscler Thromb Vasc Biol (2003) 0.92
Chronic mevastatin modulates receptor-dependent vascular contraction in eNOS-deficient mice. Am J Physiol Regul Integr Comp Physiol (2004) 0.92
Cerebral vascular effects of reactive oxygen species: recent evidence for a role of NADPH-oxidase. Clin Exp Pharmacol Physiol (2003) 0.92
Isoflavones, equol and cardiovascular disease: pharmacological and therapeutic insights. Curr Med Chem (2007) 0.91
Post-stroke inflammation and the potential efficacy of novel stem cell therapies: focus on amnion epithelial cells. Front Cell Neurosci (2013) 0.91
The angiotensin AT2 receptor in left ventricular hypertrophy. J Hypertens (2010) 0.90
The arterial depressor response to chronic low-dose angiotensin II infusion in female rats is estrogen dependent. Am J Physiol Regul Integr Comp Physiol (2011) 0.90
Impaired NO-dependent inhibition of store- and receptor-operated calcium entry in pulmonary vascular smooth muscle after chronic hypoxia. Am J Physiol Lung Cell Mol Physiol (2005) 0.90
NADPH-induced contractions of mouse aorta do not involve NADPH oxidase: a role for P2X receptors. J Pharmacol Exp Ther (2006) 0.90